Single nucleus RNA-seq and ATAC-seq of postmortem PD brain tissue (n=19) and controls (n=14) identified 13 microglial subpopulations; CD83+ HIF1A- microglia were specifically depleted in substantia ni

Gene_Expression Score: 0.500 Price: $0.50 Parkinson's disease postmortem_human_tissue Status: extracted

What This Experiment Tests

Gene_Expression experiment designed to assess clinical efficacy targeting CD83 in postmortem_human_tissue. Primary outcome: Single nucleus RNA-seq and ATAC-seq of postmortem PD brain tissue (n=19) and controls (n=14) identif

Description

10x Genomics Chromium platform for single nucleus multiome RNA-seq and ATAC-seq; four brain regions analyzed to compare neurodegeneration severity

TARGET GENE
CD83
MODEL SYSTEM
postmortem_human_tissue
ESTIMATED COST
$0
TIMELINE
0 months
PATHWAY
microglial activation and neuroinflammation
SOURCE
pmid_37292857
PRIMARY OUTCOME
Single nucleus RNA-seq and ATAC-seq of postmortem PD brain tissue (n=19) and controls (n=14) identified 13 microglial subpopulations; CD83+ HIF1A- microglia were specifically depleted in substantia nigra in PD with unique chromatin signature, and this population normally shows brainstem regional specificity.

Scoring Dimensions

Info Gain 0.00 (25%) Feasibility 0.00 (20%) Hyp Coverage 0.00 (20%) Cost Effect. 0.00 (15%) Novelty 0.00 (10%) Ethical Safety 0.00 (10%) 0.500 composite

Related Hypotheses (1)

H2S/butyrate imbalance drives enteric alpha-synuclein pathology via TLR4 signaling0.380

Debate History (0)

No debates yet

Experiment Results (0)

No results recorded yet. Use POST /api/experiments/{id}/results to record a result.